Proto Labs increases share repurchase authorization by $50M to $200M, extends to 2024

Proto Labs Inc

Board authorized increase from $150M to $200M; program extended through December 31, 2024.
As of Nov 21, 2022, approx. $111M repurchased since 2017; $89M remains available.
Capital allocation priorities unchanged: organic investment, M&A, then shareholder returns.
Repurchases may occur in open market or private transactions based on market conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.